Trevi Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | 05/15/2026 | 13.22 M | $157.74 M | 0.00% | 9.09% |
| BLACKROCK, INC. | 05/13/2026 | 10.24 M | $122.17 M | 1.13% | 7.04% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 9.94 M | $118.58 M | -3.12% | 6.83% |
| FMR LLC | 05/15/2026 | 8.04 M | $95.89 M | 23.66% | 5.52% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 5.19 M | $61.91 M | 52.44% | 3.57% |
| VIVO CAPITAL, LLC | 05/20/2026 | 5.09 M | $60.78 M | 0.00% | 3.50% |
| 05/15/2026 | 4.98 M | $59.39 M | 100.00% | 3.42% | |
| MARSHALL WACE, LLP | 05/15/2026 | 3.97 M | $47.31 M | -13.42% | 2.73% |
| RUBRIC CAPITAL MANAGEMENT LP | 05/15/2026 | 3.71 M | $44.29 M | -1.44% | 2.55% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 3.30 M | $39.35 M | 0.35% | 2.27% |
| VIKING GLOBAL INVESTORS LP | 05/15/2026 | 3.20 M | $38.16 M | 0.00% | 2.20% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2026 | 2.85 M | $35.63 M | -7.70% | 1.96% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.78 M | $33.15 M | 15.14% | 1.91% |
| STATE STREET CORP | 05/15/2026 | 2.67 M | $31.80 M | 9.46% | 1.83% |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2026 | 2.62 M | $31.28 M | 0.00% | 1.80% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 2.45 M | $29.28 M | -23.08% | 1.69% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 2.40 M | $28.63 M | 54.84% | 1.65% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 2.17 M | $25.85 M | 100.00% | 1.49% |
| ACORN CAPITAL ADVISORS, LLC | 05/15/2026 | 2.14 M | $25.59 M | 0.00% | 1.47% |
| ARTIA GLOBAL PARTNERS LP | 05/15/2026 | 2.01 M | $24.02 M | 0.00% | 1.38% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 2.00 M | $23.86 M | -6.98% | 1.37% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 05/15/2026 | 1.99 M | $23.79 M | 79.91% | 1.37% |
| EMERALD ADVISERS, LLC | 05/04/2026 | 1.84 M | $21.95 M | -2.79% | 1.26% |
| SIREN, L.L.C. | 05/14/2026 | 1.79 M | $21.32 M | -21.86% | 1.23% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 1.71 M | $20.35 M | 11.36% | 1.17% |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 1.69 M | $20.14 M | -4.47% | 1.16% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 1.62 M | $19.33 M | 80.00% | 1.11% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 05/14/2026 | 1.55 M | $18.54 M | 23.63% | 1.07% |
| OCTAGON CAPITAL ADVISORS LP | 05/15/2026 | 1.49 M | $17.72 M | -47.25% | 1.02% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 05/04/2026 | 1.26 M | $15.06 M | -0.78% | 0.87% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.23 M | $14.65 M | 16.17% | 0.84% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 1.22 M | $14.52 M | 11.15% | 0.84% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.20 M | $14.33 M | 686.03% | 0.83% |
| NAN FUNG TRINITY (HK) LTD | 05/05/2026 | 1.14 M | $13.64 M | 24.58% | 0.79% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 05/05/2026 | 1.06 M | $12.69 M | 0.94% | 0.73% |
| WOODLINE PARTNERS LP | 05/15/2026 | 1.00 M | $11.94 M | 0.05% | 0.69% |
| 05/08/2026 | 968.59 K | $11.56 M | 100.00% | 0.67% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 840.57 K | $10.03 M | 0.45% | 0.58% |
| NORTHERN TRUST CORP | 05/14/2026 | 806.66 K | $9.62 M | 5.87% | 0.55% |
| CANDRIAM S.C.A. | 04/30/2026 | 773.62 K | $9.23 M | 100.00% | 0.53% |
| MORGAN STANLEY | 05/15/2026 | 731.26 K | $8.72 M | -30.38% | 0.50% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 714.63 K | $8.53 M | 100.00% | 0.49% |
| PANAGORA ASSET MANAGEMENT INC | 05/14/2026 | 625.58 K | $7.46 M | -9.73% | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2026 | 574.03 K | $6.85 M | -4.09% | 0.39% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 570.97 K | $6.81 M | 0.13% | 0.39% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 04/23/2026 | 530.45 K | $6.33 M | 4.48% | 0.36% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 05/15/2026 | 525.00 K | $6.26 M | 0.00% | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2026 | 511.13 K | $6.10 M | -5.56% | 0.35% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 504.84 K | $6.02 M | 55.73% | 0.35% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 473.85 K | $5.65 M | 171.33% | 0.33% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Trevi Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 221 institutional investors and hedge funds held shares of Trevi Therapeutics Inc. The most heavily invested institutionals were:
NEA Management Company, LLC: 13.22 M
BlackRock, Inc.: 10.24 M
Frazier Life Sciences Management, L.P.: 9.94 M
FMR LLC: 8.04 M
WELLINGTON MANAGEMENT GROUP LLP: 5.19 M
Vivo Capital, LLC: 5.09 M
92.73% of Trevi Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 142.77 M shares in the last 24 months. This purchase volume represents approximately $1.67 B in transactions.